• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Omeros

Anonymous

Guest
Whats up with this company? I rec'd a call from a recruiter that they were all hot to trot getting someone to Dallas for an interview. She said that they were looking for ophtho experience but when it came down to it they did not pay for any experience. I hope for those that did get an interview, that this company understands that w/o ophtho exp. they will be getting started on the wrong foot. Can you say "one trick pony".
 












Well, well, well
Reaction-Picture-Well-well-well.jpg